PING AN BIOMEDICAL CO., LTD. (PASW) Return on equity
PING AN BIOMEDICAL CO., LTD. (PASW) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-28.4%FY2025
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -28.4% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More PASW financial trends
PASW RevenuePASW Net incomePASW Net marginPASW Gross profitPASW Gross marginPASW Operating incomePASW Operating marginPASW Operating cash flowPASW Free cash flowPASW Capital expendituresPASW Stock buybacksPASW Dividends paidPASW Total assetsPASW Total liabilitiesPASW Shareholders’ equityPASW overview →